Brentuximab Vedotin Plus AVD for Non-Bulky Limited Stage Classical Hodgkin Lymphoma: A Phase 2 Trial.

Brentuximab Vedotin Plus AVD for Non-Bulky Limited Stage Classical Hodgkin Lymphoma: A Phase 2 Trial. Clin Adv Hematol Oncol. 2015 Aug;13(8 Suppl 9):17-8 Authors: PMID: 26862876 [PubMed - in process]
Source: Clinical Advances in Hematology and Oncology - Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research